Chemeca Drugs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PIRFENIDONE USP, with a corresponding US DMF Number 40359.
Remarkably, this DMF maintains an Active status since its submission on September 30, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 22, 2025, and payment made on September 24, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II